Skip to main content
Retour
Watch Compare

Welsis Corp.

Qualité des données : 100%
WLSS
OTC Services Health Services
4,60 €
0,00 € (0,00%)
Cap. Boursière: 12,66 M
Prix
4,60 €
Cap. Boursière
12,66 M
Fourchette du Jour
3,47 € — 3,50 €
Fourchette 52 Semaines
0,40 € — 4,64 €
Volume
600
Ouverture 3,47 €
Moyenne 50J / 200J
3,94 €
16,64% above
Moyenne 50J / 200J
3,16 €
45,36% above

Quick Summary

Points Clés

Negative free cash flow of -51 183,0

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio0,01
Interest Coverage-3,10

Valorisation

PE (TTM)
-272,58
En dessous de la moyenne du secteur (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (502 pairs)
Métrique Action Médiane du Secteur
P/E -272,6 -1,2
P/B — 1,4
ROE % — -16,0
Net Margin % — -19,4
Rev Growth 5Y % — 4,0
D/E — 0,4

All Fundamental Metrics
Growth
Revenue Growth (1Y) -100,00% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -46 454,0
ROE N/A ROA -2819,67%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -51 183,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,01
Interest Coverage -3,10 Asset Turnover 0,00
Working Capital -81 934 Tangible Book Value -160 351
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -272,58 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,40%
Market Cap 12,66 M Enterprise Value 12,66 M
Per Share
EPS (Diluted TTM) -0,01 Revenue / Share 0,00
FCF / Share -0,02 OCF / Share -0,02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 110,18%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue 0,0 2 000,0 15 900,0 0,0
Net Income -60 690,0 -24 683,0 -41 068,0 -42 785,0
EPS (Diluted) -0,02 0,00 0,00 0,00
Gross Profit 0,0 2 000,0 — —
Operating Income -50 573,0 -57 898,0 -41 068,0 -42 785,0
EBITDA — — — —
R&D Expenses — — — —
SG&A Expenses — — — —
D&A — — — —
Interest Expense 10 117,0 6 452,0 — —
Income Tax — — 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 2 169,0 0,0 33 167,0 50 036,0
Total Liabilities 152 500,0 89 641,0 151 140,0 126 941,0
Shareholders' Equity -150 331,0 -89 641,0 -117 973,0 -76 905,0
Total Debt — — — —
Cash & Equivalents — — — —
Current Assets 2 169,0 0,0 9 834,0 18 703,0
Current Liabilities 84 608,0 71 696,0 111 140,0 86 941,0